Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,532.0
-13.5 (-0.53%)

 

  • STI Straits Times Index
    2,532.0
    -13.5 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,575.8
    4.2 (0.26%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,925.3
    547.8 (2.25%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,374.3
    -5.0 (-0.15%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,750.2
    420.3 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,191.6
    33.8 (0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 917.9M
  • Value: 1,042.2M
  • Rise: 155
  • Fall: 166
  • Unch: 488

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.018+0.001
Oceanus^0.008-
ISDN0.430+0.035
ThaiBev0.605-
Polaris0.002-0.001
Keppel Corp4.810-0.590
Intl Cement0.045+0.020
China Real Estate0.002-
Acromec0.156+0.069
Vicplas Intl0.400+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NOVA EYE MEDICAL LIMITED NOVA EYE MEDICAL
Updated on 10 Aug 2020 (End of trading day)
Last (AUD): 0.320 Change: -0.010 High: 0.335 Remarks: -
Change (%): -3.03 Low: 0.310
Open 0.320 Yesterday's Close 0.33
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 336,605 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.04020 Trailing EPS (AUD) e -0.04006 NAV (AUD) b -
PE a - Trailing PE f - Price / NAV b -
Dividend (AUD) d - Cash In Hand (AUD) g - Issued & Paid-up Shares c 143,601,000
Dividend Yield (%) d - Price / Cash In Hand g - Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 45.952
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 45.952
Piotroski F Score - Exchange Code EYE Par Value ( AUD ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 71.4
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 03 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 03 Jul 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NOVA EYE MEDICAL LIMITED ASX 45.952 - - - -
Industry Medical Specialties ASX 1,949.396 56.034 54.122 21.5225 0.611
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 18,761.144 68.725 68.726 19.8903 0.941
Local Peer COCHLEAR LTD ASX 12,564.686 45.409 41.088 15.5890 1.516
Local Peer EBOS GROUP ASX 3,286.717 23.869 21.576 2.5583 3.444
Local Peer NANOSONICS LIMITED ASX 1,899.817 139.669 155.621 16.1595 -
Local Peer MCP INCOME OPPORTUNITIES TRUST ASX 506.980 - - -355.1020 -
Local Peer AROA BIOSURGERY LTD ASX 420.105 - - 56.9106 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 399.647 384.956 348.732 8.9982 0.656
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 326.562 - - 6.4564 -
Local Peer ATOMO DIAGNOSTICS LIMITED ASX 221.626 - - - -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 110.936 - - 15.5512 -
Local Peer RESAPP HEALTH LIMITED ASX 105.717 - - 22.2222 -
Local Peer CYCLOPHARM LIMITED ASX 108.371 - - 4.6697 0.722
Other Local Peers SOMNOMED LIMITED (ASX), RESPIRI LTD (ASX), DIMERIX LTD (ASX), SDI LTD (ASX), IMPEDIMED LIMITED (ASX), COMPUMEDICS (ASX), RESONANCE HEALTH LTD (ASX), MICRO-X LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), INCANNEX HEALTHCARE LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LBT INNOVATIONS LTD (ASX), OVENTUS MEDICAL LTD (ASX), CARDIEX LTD (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OPTISCAN IMAGING (ASX), ADHERIUM LIMITED (ASX), ANALYTICA (ASX), DORSAVI LTD (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Global Peer ABBOTT LABORATORIES NYSE 177,123.821 48.315 57.639 5.7925 1.313
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 162,254.784 43.900 43.782 5.4311 0.187
Global Peer DANAHER CORP NYSE 143,336.088 57.592 49.069 4.3443 0.330
Global Peer MEDTRONIC PLC NYSE 134,639.694 28.114 28.114 2.6537 2.151
Global Peer INTUITIVE SURGICAL INC NASDAQ 79,928.758 57.949 70.360 9.1446 -
Global Peer BECTON DICKINSON & CO NYSE 74,423.866 68.784 96.155 3.0984 1.119
Global Peer STRYKER CORP NYSE 70,489.978 33.841 44.029 5.5269 1.134
Global Peer BOSTON SCIENTIFIC CORP NYSE 55,767.517 11.865 14.012 3.5712 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 47,402.088 36.291 42.544 3.8536 1.723
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,115.533 45.005 63.361 12.2725 -
Other Global Peers DEXCOM INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), AGILENT TECHNOLOGIES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), Top Glove (SGX), HOLOGIC INC (NASDAQ), TOPGLOV (Bursa), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), HARTA (Bursa), INSULET CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), PERKINELMER INC (NYSE), WATERS CORP (NYSE), STERIS PLC (NYSE), WEIGAO GROUP (HKEx), MASIMO CORPORATION (NASDAQ), QUIDEL CORP (NASDAQ), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), MICROPORT (HKEx), PENUMBRA INC (NYSE), NOVOCURE LTD (NASDAQ), SUPERMX (Bursa), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), NEVRO CORP (NYSE), KANGJI MEDICAL (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HAEMONETICS CORP (NYSE), WRIGHT MEDICAL GROUP NV (NASDAQ), VENUS MEDTECH-B (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), ICU MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), INARI MEDICAL INC (NASDAQ), AK MEDICAL (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), CONMED CORP (NYSE), LIVANOVA PLC (NASDAQ), PEIJIA-B (HKEx), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), ATRICURE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), AVANOS MEDICAL INC (NYSE), BIOTELEMETRY INC (NASDAQ), CIRC (HKEx), MESA LABORATORIES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), KDL MEDICAL (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), LIFETECH SCI (HKEx), INMODE LTD (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), VERICEL CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), NATUS MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ZYNEX INC (NASDAQ), SI BONE INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), AXOGEN INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VIEWRAY INC (NASDAQ), UG Healthcare (SGX), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), YESTAR HEALTH (HKEx), Medtecs Intl (SGX), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PW MEDTECH (HKEx), RETRACTABLE TECHNOLOGIES INC (NYSE American), GOLDEN MEDITECH (HKEx), PROFOUND MED CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), ALPHA PRO TECH (NYSE American), IRADIMED CORP (NASDAQ), CUTERA INC (NASDAQ), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), CORMEDIX INC (NYSE American), ACCURAY INCORPORATED (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), VINCENT MED (HKEx), FONAR CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), LKL (Bursa), ELECTROMED INC (NYSE American), SOLITON INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), INTRICOM CORP (NASDAQ), BIOMERICA INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), ELECTROCORE INC (NASDAQ), Biolidics (SGX), DAXOR CORP (NYSE American), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), YUNNAN ENERGY (HKEx), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEURONETICS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ONCOCYTE CORP (NYSE American), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), CONFORMIS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), IMMUCELL CORP (NASDAQ), KELFRED (HKEx), THERMOGENESIS HOLDINGS INC (NASDAQ), CELSION CORPORATION (NASDAQ), AVINGER INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), Yunnan Energy (SGX), IRIDEX CORP (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NEUROTROPE INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), LIFE HEALTHCARE (HKEx), REWALK ROBOTICS LTD (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), CHECK-CAP LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), CYANOTECH CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), DIGIRAD CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DYNATRONICS CORP (NASDAQ), Annica (SGX), STHAI (SET), VIVEVE MEDICAL INC (NASDAQ), NEUROMETRIX INC (NASDAQ), CANCER GENETICS INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.005
+1.59 %
10 Days --0.010
-3.03 %
20 Days --0.077
-19.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.285 - 0.494 Change From 1 Year Low +0.035 % Change From 1 Year Low (%) +12.28
Change From 1 Year High -0.174 % Change From 1 Year High (%) -35.28
2 Years Range 0.285 - 0.494 Change From 2 Years Low +0.035 % Change From 2 Years Low (%) +12.28
Change From 2 Years High -0.174 % Change From 2 Years High (%) -35.28
5 Years Range 0.285 - 0.494 Change From 5 Years Low +0.035 % Change From 5 Years Low (%) +12.28
Change From 5 Years High -0.174 % Change From 5 Years High (%) -35.28
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Adelaide, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
10 Aug 2020 0.320 0.335 0.310 0.320 336,605 -
07 Aug 2020 0.325 0.340 0.325 0.330 146,665 -
06 Aug 2020 0.310 0.335 0.310 0.325 215,344 -
05 Aug 2020 0.310 0.335 0.310 0.315 205,846 -
04 Aug 2020 0.315 0.320 0.310 0.310 122,962 -
03 Aug 2020 0.335 0.335 0.305 0.315 314,200 -
31 Jul 2020 0.330 0.335 0.325 0.330 151,368 -
30 Jul 2020 0.330 0.345 0.330 0.335 114,082 -
29 Jul 2020 0.330 0.340 0.320 0.330 111,069 -
28 Jul 2020 0.320 0.330 0.320 0.330 101,428 -
27 Jul 2020 0.320 0.345 0.310 0.330 89,438 -
24 Jul 2020 0.310 0.340 0.285 0.330 3,031,385 -
23 Jul 2020 0.365 0.365 0.315 0.315 992,623 -
22 Jul 2020 0.400 0.405 0.365 0.370 820,898 -
21 Jul 2020 0.390 0.422 0.350 0.390 2,842,275 -
20 Jul 2020 0.441 0.494 0.441 0.485 2,358,383 -
17 Jul 2020 0.435 0.438 0.416 0.425 393,810 -
16 Jul 2020 0.416 0.438 0.413 0.435 1,316,024 -
15 Jul 2020 0.407 0.419 0.407 0.419 213,091 -
14 Jul 2020 0.397 0.422 0.397 0.416 444,700 -
13 Jul 2020 0.425 0.425 0.397 0.397 187,839 -
10 Jul 2020 0.425 0.425 0.425 0.425 - -
Summary
Current 2 Weeks
(28 Jul 2020 to 10 Aug 2020)
0.320 0.345 0.305 0.320 1,819,569 -
Previous 2 Weeks
(14 Jul 2020 to 27 Jul 2020)
0.397 0.422 0.305 0.330 12,502,627 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.